Screener
Praxis Precision Medicines, Inc. PRAX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s total equity?
- Praxis Precision Medicines, Inc. (PRAX) reported total equity of $1.34B in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s total equity changed year-over-year?
- Praxis Precision Medicines, Inc.'s total equity increased by 231.8% year-over-year, from $404.22M to $1.34B.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total equity?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total equity has grown at a 25.0% compound annual growth rate (CAGR), from $287.46M to $878.14M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Praxis Precision Medicines, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude